Keywords
Last Name
Institution

Juan C. Bandres

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentMedicine
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lieberman-Blum SS, Fung HB, Bandres JC. Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection. Clin Ther. 2008 Jul; 30(7):1228-50.
      View in: PubMed
    2. Jeffs SA, Gorny MK, Williams C, Revesz K, Volsky B, Burda S, Wang XH, Bandres J, Zolla-Pazner S, Holmes H. Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120. Immunol Lett. 2001 Dec 3; 79(3):209-13.
      View in: PubMed
    3. Hioe CE, Chien PC, Lu C, Springer TA, Wang XH, Bandres J, Tuen M. LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. J Virol. 2001 Jan; 75(2):1077-82.
      View in: PubMed
    4. Staudinger R, Bandres JC. Solubilization of the chemokine receptor CXCR4. Biochem Biophys Res Commun. 2000 Jul 21; 274(1):153-6.
      View in: PubMed
    5. Lallos LB, Laal S, Hoxie JA, Zolla-Pazner S, Bandres JC. Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. AIDS Res Hum Retroviruses. 1999 Jul 1; 15(10):895-7.
      View in: PubMed
    6. Bandres JC, Wang QF, O'Leary J, Baleaux F, Amara A, Hoxie JA, Zolla-Pazner S, Gorny MK. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J Virol. 1998 Mar; 72(3):2500-4.
      View in: PubMed
    7. Carey WP, Kaykova Y, Bandres JC, Sidhu GS, Bräu N. Cutaneous protothecosis in a patient with AIDS and a severe functional neutrophil defect: successful therapy with amphotericin B. Clin Infect Dis. 1997 Nov; 25(5):1265-6.
      View in: PubMed
    8. Ratner L, Joseph T, Bandres J, Ghosh S, Vander Heyden N, Templeton A, Hahn B, Powderly W, Arens M. Sequence heterogeneity of Nef transcripts in HIV-1-infected subjects at different stages of disease. Virology. 1996 Sep 1; 223(1):245-50.
      View in: PubMed
    9. Vadhan-Raj S, Broxmeyer HE, Andreeff M, Bandres JC, Buescher ES, Benjamin RS, Papadopoulos NE, Burgess A, Patel S, Plager C, Hittelman WN, McAlister I, Garrison L, Williams DE. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study. Blood. 1995 Sep 15; 86(6):2098-105.
      View in: PubMed
    10. Rodriguez-Barradas MC, Bandres JC, Hamill RJ, Trial J, Clarridge JE, Baughn RE, Rossen RD. In vitro evaluation of the role of humoral immunity against Bartonella henselae. Infect Immun. 1995 Jun; 63(6):2367-70.
      View in: PubMed
    11. Bandres JC, Shaw AS, Ratner L. HIV-1 Nef protein downregulation of CD4 surface expression: relevance of the lck binding domain of CD4. Virology. 1995 Feb 20; 207(1):338-41.
      View in: PubMed
    12. Birdsall HH, Trial J, Hallum JA, de Jong AL, Green LK, Bandres JC, Smole SC, Laughter AH, Rossen RD. Phenotypic and functional activation of monocytes in HIV-1 infection: interactions with neural cells. J Leukoc Biol. 1994 Sep; 56(3):310-7.
      View in: PubMed
    13. Bandres JC, Luria S, Ratner L. Regulation of human immunodeficiency virus Nef protein by phosphorylation. Virology. 1994 May 15; 201(1):157-61.
      View in: PubMed
    14. Bandres JC, Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J Virol. 1994 May; 68(5):3243-9.
      View in: PubMed
    15. Bandres JC, Trial J, Musher DM, Rossen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis. 1993 Jul; 168(1):75-83.
      View in: PubMed
    16. Niederman TM, Hastings WR, Luria S, Bandres JC, Ratner L. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology. 1993 May; 194(1):338-44.
      View in: PubMed
    17. Bandres JC, White AC, Samo T, Murphy EC, Harris RL. Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis. 1992 Nov; 15(5):799-811.
      View in: PubMed
    18. Bandres J, Yao L, Nemoto EM, Yonas H, Darby J. Effects of dobutamine and dopamine on whole brain blood flow and metabolism in unanesthetized monkeys. J Neurosurg Anesthesiol. 1992 Oct; 4(4):250-6.
      View in: PubMed
    19. Bandres JC, Mathewson JJ, Ericsson CD, Dupont HL. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico. Am J Med Sci. 1992 May; 303(5):289-91.
      View in: PubMed
    20. Bandres JC, Darouiche RO. Staphylococcus capitis endocarditis: a new cause of an old disease. Clin Infect Dis. 1992 Jan; 14(1):366-7.
      View in: PubMed
    21. Yao LP, Bandres J, Nemoto EM, Boston JR, Darby JM, Yonas H. Effect of 33% xenon inhalation on whole-brain blood flow and metabolism in awake and fentanyl-anesthetized monkeys. Stroke. 1992 Jan; 23(1):69-74.
      View in: PubMed
    22. Bandres JC, Mathewson JJ, DuPont HL. Heat susceptibility of bacterial enteropathogens. Implications for the prevention of travelers' diarrhea. Arch Intern Med. 1988 Oct; 148(10):2261-3.
      View in: PubMed
    Bandres's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067